Go to Client Portal
NAMSA

The New ISO 10993-18:2020 – 10 Things Manufacturers Need To Know Today

About

Date/Time

On Demand

Access this On-Demand Webinar Here. 

With the most recent release of ISO 10993-18 (January 2020), further developed is the concept of Biological Evaluation of Medical Devices within a Risk Management Process. This critical information has been long waited for by global medical device manufacturers provided the original release of ISO 10993-1 was in 2005 (with an updated version in 2018). Now, with the new standard available, it is critical that professionals involved with the biological evaluation of medical devices understand the standard’s use, interpretation, requirements and how an effective link now exists to the overall biocompatibility evaluation as described in ISO 10993-1.

This LIVE webinar, presented by Don Pohl (Principal Product Development Strategist—NAMSA), will take look at ISO 10993-18:2020 and highlight the key aspects which have been incorporated into the standard and how these may impact strategies developed for the safety evaluation of a device. Some key questions to be discussed and presented include:

  • What are the most significant changes to the standard?
  • How has the chemical characterization process changed with the release of this standard?
  • How can I use chemical characterization in the biological evaluation of my device?
  • What do I need to start doing differently today because of this update?

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebcast, to host NAMSA webinars. For information related to GoToWebcast’s privacy policy and utilization of information, please contact GoToWebcast directly.